CD44 and neoplasm: Apart from the miR-449a, we have previously demonstrated that ICG-001 could also inhibit the growth of CSC-enriched NPC tumor spheroids via miR-145/SOX2 axis [22] and the NPC cell migration via miR-150/CD44 axis [23].